Cargando…
Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France
OBJECTIVES: Patient- and procedure-related changes in modern medicine have turned CoNS into one of the major nosocomial pathogens. Treatments of CoNS infections are challenging owing to the large proportion of MDR strains and oxazolidinones often remain the last active antimicrobial molecules. Here,...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890688/ https://www.ncbi.nlm.nih.gov/pubmed/29092052 http://dx.doi.org/10.1093/jac/dkx370 |
_version_ | 1783312908361400320 |
---|---|
author | Dortet, Laurent Glaser, Philippe Kassis-Chikhani, Najiby Girlich, Delphine Ichai, Philippe Boudon, Marc Samuel, Didier Creton, Elodie Imanci, Dilek Bonnin, Rémy Fortineau, Nicolas Naas, Thierry |
author_facet | Dortet, Laurent Glaser, Philippe Kassis-Chikhani, Najiby Girlich, Delphine Ichai, Philippe Boudon, Marc Samuel, Didier Creton, Elodie Imanci, Dilek Bonnin, Rémy Fortineau, Nicolas Naas, Thierry |
author_sort | Dortet, Laurent |
collection | PubMed |
description | OBJECTIVES: Patient- and procedure-related changes in modern medicine have turned CoNS into one of the major nosocomial pathogens. Treatments of CoNS infections are challenging owing to the large proportion of MDR strains and oxazolidinones often remain the last active antimicrobial molecules. Here, we have investigated a long-lasting outbreak (2010–13) due to methicillin- and linezolid-resistant (LR) CoNS (n = 168), involving 72 carriers and 49 infected patients. METHODS: Antimicrobial susceptibilities were tested by the disc diffusion method and MICs were determined by broth microdilution or Etest. The clonal relationship of LR Staphylococcus epidermidis (LRSE) was first determined using a semi-automated repetitive element palindromic PCR (rep-PCR) method. Then, WGS was performed on all cfr-positive LRSE (n = 30) and LRSE isolates representative of each rep-PCR-defined clone (n = 17). Self-transferability of cfr-carrying plasmids was analysed by filter-mating experiments. RESULTS: This outbreak was caused by the dissemination of three clones (ST2, ST5 and ST22) of LRSE. In these clones, linezolid resistance was caused by (i) mutations in the chromosome-located genes encoding the 23S RNA and L3 and L4 ribosomal proteins, but also by (ii) the dissemination of two different self-conjugative plasmids carrying the cfr gene encoding a 23S RNA methylase. By monitoring linezolid prescriptions in two neighbouring hospitals, we highlighted that the spread of LR-CoNS was strongly associated with linezolid use. CONCLUSIONS: Physicians should be aware that plasmid-encoded linezolid resistance has started to disseminate among CoNS and that rational use of oxazolidinones is critical to preserve these molecules as efficient treatment options for MDR Gram-positive pathogens. |
format | Online Article Text |
id | pubmed-5890688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58906882018-04-13 Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France Dortet, Laurent Glaser, Philippe Kassis-Chikhani, Najiby Girlich, Delphine Ichai, Philippe Boudon, Marc Samuel, Didier Creton, Elodie Imanci, Dilek Bonnin, Rémy Fortineau, Nicolas Naas, Thierry J Antimicrob Chemother Original Research OBJECTIVES: Patient- and procedure-related changes in modern medicine have turned CoNS into one of the major nosocomial pathogens. Treatments of CoNS infections are challenging owing to the large proportion of MDR strains and oxazolidinones often remain the last active antimicrobial molecules. Here, we have investigated a long-lasting outbreak (2010–13) due to methicillin- and linezolid-resistant (LR) CoNS (n = 168), involving 72 carriers and 49 infected patients. METHODS: Antimicrobial susceptibilities were tested by the disc diffusion method and MICs were determined by broth microdilution or Etest. The clonal relationship of LR Staphylococcus epidermidis (LRSE) was first determined using a semi-automated repetitive element palindromic PCR (rep-PCR) method. Then, WGS was performed on all cfr-positive LRSE (n = 30) and LRSE isolates representative of each rep-PCR-defined clone (n = 17). Self-transferability of cfr-carrying plasmids was analysed by filter-mating experiments. RESULTS: This outbreak was caused by the dissemination of three clones (ST2, ST5 and ST22) of LRSE. In these clones, linezolid resistance was caused by (i) mutations in the chromosome-located genes encoding the 23S RNA and L3 and L4 ribosomal proteins, but also by (ii) the dissemination of two different self-conjugative plasmids carrying the cfr gene encoding a 23S RNA methylase. By monitoring linezolid prescriptions in two neighbouring hospitals, we highlighted that the spread of LR-CoNS was strongly associated with linezolid use. CONCLUSIONS: Physicians should be aware that plasmid-encoded linezolid resistance has started to disseminate among CoNS and that rational use of oxazolidinones is critical to preserve these molecules as efficient treatment options for MDR Gram-positive pathogens. Oxford University Press 2018-01 2017-10-30 /pmc/articles/PMC5890688/ /pubmed/29092052 http://dx.doi.org/10.1093/jac/dkx370 Text en © The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. |
spellingShingle | Original Research Dortet, Laurent Glaser, Philippe Kassis-Chikhani, Najiby Girlich, Delphine Ichai, Philippe Boudon, Marc Samuel, Didier Creton, Elodie Imanci, Dilek Bonnin, Rémy Fortineau, Nicolas Naas, Thierry Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France |
title | Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France |
title_full | Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France |
title_fullStr | Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France |
title_full_unstemmed | Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France |
title_short | Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France |
title_sort | long-lasting successful dissemination of resistance to oxazolidinones in mdr staphylococcus epidermidis clinical isolates in a tertiary care hospital in france |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890688/ https://www.ncbi.nlm.nih.gov/pubmed/29092052 http://dx.doi.org/10.1093/jac/dkx370 |
work_keys_str_mv | AT dortetlaurent longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT glaserphilippe longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT kassischikhaninajiby longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT girlichdelphine longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT ichaiphilippe longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT boudonmarc longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT samueldidier longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT cretonelodie longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT imancidilek longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT bonninremy longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT fortineaunicolas longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance AT naasthierry longlastingsuccessfuldisseminationofresistancetooxazolidinonesinmdrstaphylococcusepidermidisclinicalisolatesinatertiarycarehospitalinfrance |